Medical device startup raises $8M
A medical device startup in the region has completed an $8-million round of Series C financing.
Kalamazoo-based Innovative Cardiovascular Solutions, or ICS, said today it received the financing to develop the Emblok system, which is designed to remove aortic blockages and keep debris from traveling to other parts of the body.
Proceeds from this round will support clinical trials in the U.S. and Europe, as well as manufacturing and operational activities.
The company said as the number of blockage removal procedures has grown, the need to also completely remove the liberated material has also grown.
The system includes two devices that can be inserted through a single puncture site: an embolic filter, which removes blockages; and a pigtail catheter to drain fluids during the procedure, which is visible under an X-ray and eliminates the need to verify positioning with dye injections.
"Our team has made significant progress refining the system's design and preparing for the U.S. pivotal trial,” said R. Kevin Plemmons, co-founder and CEO, Innovative Cardiovascular Solutions.
Plemmons added the company is in discussions with the U.S. Food and Drug Administration to finalize "the pivotal trial design" and then it will demonstrate the system's "clinical impact during structural heart procedures."
The Emblok system is available for investigational use only and is not approved for sale.